C07C 233/65
Having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms
Official title: having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
C07C233/65 (Having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms) appears on 398 US grants and 416 published applications in this corpus.
Search patents in C07C- Granted patents
- 398
- Published applications
- 416
- Assignees
- 269
- Inventors
- 1,286
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 5 | 0 |
| 1992 | 4 | 0 |
| 1993 | 8 | 0 |
| 1994 | 5 | 0 |
| 1995 | 8 | 0 |
| 1996 | 12 | 0 |
| 1997 | 12 | 0 |
| 1998 | 13 | 0 |
| 1999 | 14 | 0 |
| 2000 | 12 | 0 |
| 2001 | 11 | 3 |
| 2002 | 6 | 10 |
| 2003 | 13 | 11 |
| 2004 | 8 | 19 |
| 2005 | 5 | 19 |
| 2006 | 9 | 11 |
| 2007 | 16 | 16 |
| 2008 | 9 | 17 |
| 2009 | 6 | 17 |
| 2010 | 9 | 10 |
| 2011 | 4 | 15 |
| 2012 | 13 | 16 |
| 2013 | 8 | 18 |
| 2014 | 23 | 27 |
| 2015 | 19 | 13 |
| 2016 | 15 | 33 |
| 2017 | 18 | 20 |
| 2018 | 12 | 19 |
| 2019 | 18 | 12 |
| 2020 | 7 | 18 |
| 2021 | 12 | 23 |
| 2022 | 11 | 22 |
| 2023 | 17 | 14 |
| 2024 | 7 | 15 |
| 2025 | 12 | 11 |
| 2026 | 5 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Substituted 3-amino-4-methylbenzenesulfonamides as small molecule inhibitors of ubiquitin-specific protease 2830 Jun 2026US 12,668,571 B2Dana-Farber Cancer Institute, Inc.
- Cyclopropylamide compounds against parasites in fish16 Jun 2026US 12,655,090 B2Intervet Inc.
- Antibacterial compounds2 Jun 2026US 12,643,875 B2The Penn State Research Foundation
- Aromatic compounds14 Apr 2026US 12,600,696 B2XENIOPRO GmbH
- Compositions comprising a retinoid X receptor (RXR) agonist, a retinoic acid receptor (RAR) agonist, or a dual RXR/RAR agonist3 Feb 2026US 12,540,121 B2Arizona Board of Regents on behalf of Arizona State University
- Amide compound24 Sep 2026US 2026/0285803 A1Mitsui Chemicals, Inc.
- Antibacterial compounds17 Sep 2026US 2026/0274816 A1The Penn State Research Foundation
- Compounds and methods for treating cancer18 Jun 2026US 2026/0166051 A1The Regents of the University of California
- Compositions Comprising a Retinoid X Receptor (RXR) Agonist, a Retinoic Acid Receptor (RAR) Agonist, or a Dual RXR/RAR Agonist16 Apr 2026US 2026/0103445 A1Arizona Board of Regents on behalf of Arizona State University
- Novel monomer and chemically recyclable polymer material comprising the same26 Mar 2026US 2026/0085055 A1Korea Institute of Science and Technology
Most cited
By later US patents
- Cyclic protein tyrosine kinase inhibitors134US 6,596,746 B1Bristol-Myers Squibb Company · 2003
- 6-(poly-substituted aryl)-4-aminopicolinates and their use as herbicides122US 7,314,849 B2Dow AgroSciences LLC · 2008
- Modulators of ATP-binding cassette transporters118US 7,598,412 B2Vertex Pharmaceuticals Incorporated · 2009
- Anilide derivatives and their use for combating botrytis104US 5,330,995 ABASF SE · 1994
- Heterocyclic compounds90US 5,017,211 ACiba-Geigy Corporation · 1991